ARCHIVES

Next Bypass Budget: Slim, Trim, Modest

This article is from The Cancer Letter archive.

Vol. 21 No. 35 | September 15, 1995

Download PDF Visit The Full Archive

Related Articles

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

FDA News: FDA Eases Two-Trial Standard For Proof Of Drug Efficacy

March 21, 1997

HHS Appeals Board Finds No Misconduct By Popovic

November 12, 1993

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

National TV Attack On Cancer Program Gets Response From Schmidt; Some NCAB Members Side With Kornberg

June 28, 1974